Rare bone metastases of the olecranon

J Palliat Med. 2008 Oct;11(8):1088-91. doi: 10.1089/jpm.2008.0085.

Abstract

Abstract Bone metastases are prevalent in patients with cancer, especially with primary lung, breast, renal cell, thyroid, and prostate carcinomas. When looking specifically at primary renal cell carcinoma, approximately 40% of patients will develop bone metastases during the course of their disease. However, distal bony involvement to the appendicular skeleton occurs less frequently, developing below the elbow and knee in approximately 7% of metastatic renal cell carcinoma patients. The incidence of olecranon metastasis is extremely rare in all cancers and so far only two cases have been reported in literature. We report the third case of an olecranon metastasis in a patient with renal cell carcinoma.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / radiotherapy
  • Bone Neoplasms / secondary*
  • Carcinoma, Renal Cell / pathology*
  • Elbow Joint / pathology
  • Humans
  • Interferons / therapeutic use
  • Kidney Neoplasms / pathology*
  • Male
  • Middle Aged
  • Palliative Care / methods

Substances

  • Antineoplastic Agents
  • Interferons